Gentamicin pharmacokinetics in old age and frailty

British Journal of Clinical Pharmacology

Volumn 71, Issue 2, 2011, Pages 224-231

  Hilmer, Sarah N ^a,b   Tran, Kim ^a,b   Rubie, Patrick ^a,b   Wright, Jason ^a,b   Gnjidic, Danijela ^a,b   Mitchell, Sarah J ^a,b   Matthews, Slade ^a   Carroll, Peter R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Age; Frailty; Gentamicin; Pharmacokinetics

Indexed keywords

CREATININE; GENTAMICIN;

ACCURACY; AGED; AGED HOSPITAL PATIENT; ARTICLE; BODY SIZE; BODY WEIGHT; CLINICAL ARTICLE; COHORT ANALYSIS; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIET; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG DISTRIBUTION; ERROR; FEMALE; FRAIL ELDERLY; FRAILTY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY CLEARANCE; KIDNEY DISEASE; LEAN BODY WEIGHT; MALE; OBSERVATIONAL METHOD; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENESCENCE; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; SYNDROME;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BODY WEIGHT; CREATININE; FEMALE; FRAIL ELDERLY; GENTAMICINS; HUMANS; KIDNEY; MALE; PROSPECTIVE STUDIES;

EID: 78650983359     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03825.x     Document Type: Article

References (34)

1. Joint Formulary Committee (editor). British National Formulary, 59th edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2010.
2. Triggs E, Charles B. Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly. Clin Pharmacokinet 1999; 37: 331-41.
3. Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, Wolfson C. Frailty: an emerging research and clinical paradigm - issues and controversies. J Gerontol A Biol Sci Med Sci 2007; 62: 731-7.
4. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-56.
5. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal 2001; 1: 323-36.
6. Hilmer SN, Perera V, Mitchell S, Murnion BP, Dent J, Bajorek B, Matthews S, Rolfson DB. The assessment of frailty in older people in acute care. Australas J Ageing 2009; 28: 182-8.
7. Hilmer SN, McLachlan AJ, LeCouteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007; 21: 217-30.
8. Mitchell SJ, Kirkpatrick CM, Le Couteur DG, Naganathan V, Sambrook PN, Seibel MJ, Blyth FM, Waite LM, Handelsman DJ, Cumming RG, Hilmer SN. Estimation of lean body weight in older community-dwelling men. Br J Clin Pharmacol 2010; 69: 118-27.
9. Mitchell SJ, Hilmer SN, Kirkpatrick CMJ, Hansen RD, Williamson DA, Singh NA, Finnegan TP, Allen BJ, Diamond TH, Diwan AD, Lloyd BD, Smith EUR, Fiatarone Singh MA. Estimation of lean body weight in older women with hip fracture. J Nutr Health Aging 2010; In Press.
10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999; 130: 461-70.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
12. Mathew TH. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust 2005; 183: 138-41.
13. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005; 16: 763-73.
14. Roberts GW, Ibsen PM, Schioler CT. Modified diet in renal disease method overestimates renal function in selected elderly patients. Age Ageing 2009; 38: 698-703.
15. Gill J, Malyuk R, Djurdjev O, Levin A. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group - a cautionary tale. Nephrol Dial Transplant 2007.
16. Pequignot R, Belmin J, Chauvelier S, Gaubert JY, Konrat C, Duron E, Hanon O. Renal function in older hospital patients is more accurately estimated using the Cockcroft-Gault formula than the modification diet in renal disease formula. J Am Geriatr Soc 2009; 57: 1638-43.
17. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-47.
18. Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, Gipson D, Colindres RE, Kshirsagar AV. SCreening for Occult Renal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med 2007; 167: 374-81.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
20. Devine BJ. Gentamicin therapy. Drug Intell Clin Pharm 1974; 8: 650-55.
21. Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet 2005; 44: 1051-65.
22. Duffull SB, Kirkpatrick CMJ, Begg EJ. Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens. Br J Clin Pharmacol 1997; 43: 125-35.
23. th Annual Population Approach Group in Australia and New Zealand (PAGANZ) Meeting, 2009 Feb 4-6; Newcastle, Australia.
24. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-71.
25. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
26. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981; 9: 503-12.
27. Triginer C, Izquierdo I, Fernandez R, Rello J, Torrent J, Benito S, Net A. Gentamicin volume of distribution in critically ill septic patients. Intensive Care Med 1990; 16: 303-6.
28. Hansen M, Christrup LL, Jarløv JO, Kampmann JP, Bonde J. Gentamicin dosing in critically ill patients. Acta Anaesthesiol Scand 2001; 45: 734-40.
29. Shlipak MG, Stehman-Breen C, Fried LF, Song X, Siscovick D, Fried LP, Psaty BM, Newman AB. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis 2004; 43: 861-7.
30. Wasen E, Isoaho R, Vahlberg T, Kivela SL, Irjala K. Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status. Scand J Clin Lab Invest 2008; 68: 484-91.
31. Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 2007; 22: 1087-92.
32. Duffull SB, Dooley MJ, Green B, Poole SG, Kirkpatrick CM. A standard weight descriptor for dose adjustment in the obese patient. Clin Pharmacokinet 2004; 43: 1167-78.
33. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener J, Fried LP. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002; 162: 2333-41.
34. Rossi S. Australian Medicines Handbook, 11th edn. Adelaide, SA: Australian Medicines Handbook Pty Ltd, 2010.